| Period Ending | Mar 31, 2010 | Mar 31, 2009 | Mar 31, 2008 | Mar 31, 2007 |
|---|
|
Total Revenue
|
2,037,397,000
|
1,511,355,000
|
1,371,467,000
|
1,137,701,000
| | Cost of Revenue | 1,634,088,000 | 1,180,220,000 | 1,066,494,000 | 852,673,000 | | |
Gross Profit
|
403,309,000
|
331,135,000
|
304,973,000
|
285,028,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 1,840,835,000 | 1,322,885,000 | 1,198,945,000 | 982,671,000 | | | |
Operating Income or Loss
|
196,563,000
|
188,470,000
|
172,522,000
|
155,030,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 196,563,000 | 188,470,000 | 172,522,000 | 155,030,000 |
|
Interest Expense | (15,012,000) | (9,818,000) | (6,956,000) | (8,410,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 42,565,000 | 29,154,000 | 34,411,000 | 25,723,000 |
|
Minority Interest | 796,000 | 176,000 | (19,000) | 1,000 |
|
|
|
Net Income From Continuing Ops | 245,029,000 | 149,713,000 | 195,678,000 | 120,748,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
245,029,000
|
149,713,000
|
195,678,000
|
120,748,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.05%